Table: begin end state 1 25 cytoplasmic 26 43 transmembrane 44 63 non-cytoplasmic 64 82 transmembrane 83 94 cytoplasmic 95 115 transmembrane 116 120 non-cytoplasmic 121 145 transmembrane 146 156 cytoplasmic 157 177 transmembrane 178 188 non-cytoplasmic 189 209 transmembrane 210 246 cytoplasmic 247 267 transmembrane 268 288 non-cytoplasmic 289 311 transmembrane 312 322 cytoplasmic 323 341 transmembrane 342 346 non-cytoplasmic 347 368 transmembrane 369 375 cytoplasmic 376 400 transmembrane 401 411 non-cytoplasmic 412 433 transmembrane 434 438 cytoplasmic
Input: >PP_3391 MVALTGELARERNDSHINELLLYRRVAWRIMPLAIICFLFSYFDRINISFAKTQMQQELG LSDAAYGLAASMFFVGYVLFEVPSSLGLKRYGAPAWICRIMVSWGLATAALVFAYTQYTL YFLRFLIGVMEAGFGPAILFYLACWFPRKHLAKMNGLWFLAVPLAGAVGGPAAGFLLGTM DGVLGLAGWHWLFLMSGLPCVLLGLLVLWKLDRDIEAAKWLSREEKDLLAENLAQDKRTA KPILGSIWRVLLTREVAIMAFIYYVVKTASYGLNFWMPHLIKSSGVQDMLWVGVLSALPY AVACIGMVLLTRHSDRTGERKRYLVYCLLAAAVGYLLACLFSDSPFAMMTALVLATAGTF IAIPIFWTIPQSTFSGLAIATGTAAINSVGQLSGIVAPVMVGKINDLTDSTYMGMLSIAP LILVACLVVMRYVRNPKS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server